Answer
Trametinib dimethyl sulfoxide (Mekinist) has a mean terminal elimination half-life of 127 hours (5.3 days) after a single dose.
Sources for this answer
- Mekinist film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 30Document updated
Sources checked